Certain Ordinary Shares of Ocumension Therapeutics are subject to a Lock-Up Agreement Ending on 9-JUL-2021. These Ordinary Shares will be under lockup for 365 days starting from 9-JUL-2020 to 9-JUL-2021. Details: The controlling shareholders of the company, 6 Dimensions Capital, L.P, 6 Dimensions Affiliates Fund, L.P., Suzhou Frontline BioVentures Venture Capital Fund II L.P., and Suzhou 6Dimensions Venture Capital Partnership L.P., have undertaken not to offer any shares held by them for a period of 6 months from the listing date. The controlling shareholders have agreed not to offer any such shares for an additional six month period, if following such disposal, they cease to be the controlling shareholders of the company.